MA37534A1 - Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans - Google Patents

Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37534A1
MA37534A1 MA37534A MA37534A MA37534A1 MA 37534 A1 MA37534 A1 MA 37534A1 MA 37534 A MA37534 A MA 37534A MA 37534 A MA37534 A MA 37534A MA 37534 A1 MA37534 A1 MA 37534A1
Authority
MA
Morocco
Prior art keywords
thyme
essential oil
antibacterial effect
actinomycetemcomitans
aaggregatibacter
Prior art date
Application number
MA37534A
Other languages
English (en)
Other versions
MA37534B1 (fr
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37534A priority Critical patent/MA37534B1/fr
Priority to PCT/MA2014/000059 priority patent/WO2016076690A1/fr
Publication of MA37534A1 publication Critical patent/MA37534A1/fr
Publication of MA37534B1 publication Critical patent/MA37534B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L’application de |’effet antibactérien de |’huile essentielle de thym (thymus vulgaris) d’origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n'a jamais fait l’objet de tests antimicrobiens à base d'huiles essentielles.Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.
MA37534A 2014-11-13 2014-11-13 Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans MA37534B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37534A MA37534B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
PCT/MA2014/000059 WO2016076690A1 (fr) 2014-11-13 2014-12-31 Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur aggregatibacter actinomycetemcomitans clone jp2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37534A MA37534B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37534A1 true MA37534A1 (fr) 2016-06-30
MA37534B1 MA37534B1 (fr) 2017-01-31

Family

ID=52684610

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37534A MA37534B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37534B1 (fr)
WO (1) WO2016076690A1 (fr)

Also Published As

Publication number Publication date
MA37534B1 (fr) 2017-01-31
WO2016076690A1 (fr) 2016-05-19

Similar Documents

Publication Publication Date Title
CY1122306T1 (el) Συνθεσεις που περιλαμβανουν bakthpiaka στελεχη
CL2020001048A1 (es) Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281)
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
IL277329A (en) Preparations of 17 beta-hydroxysteroid dehydrogenase type 13iRNA and methods of using them
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
CL2020001391A1 (es) Formulación liofilizada de un anticuerpo monoclonal contra la transtirretina.
BR112018015792A2 (pt) composições para higiene bucal e métodos de uso destas
NZ725569A (en) Lubricant formulations
BR112017007393A2 (pt) composições de anticorpo anti-il-7r
MX2024010027A (es) Anticuerpos contra el vih ampliamente neutralizantes y metodos de uso de ellos.
MX2021006977A (es) Anellosomas y metodos de uso.
ITUA20161822A1 (it) Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
MA43314A (fr) Vecteurs de grippe atténues utilisés pour la prophylaxie et/ou le traitement de maladies infectieuses ainsi que pour le traitement de maladies oncologiques
BR112016028518A2 (pt) composições farmacêuticas que compreendem dgla e uso do mesmo
CL2023003696A1 (es) Anticuerpos anti-pcrv que se unen a pcrv, composiciones que comprenden anticuerpos anti-pcrv, métodos de uso
AR111099A1 (es) Uso de un suero para el lavado de ropa
EA202091259A1 (ru) Способ получения опикапона и его интермедиатов
BR102019017062A8 (pt) Composições tópicas compreendendo pichia anomala e retinol
MA37534A1 (fr) Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37532B1 (fr) Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37533A1 (fr) Composition pharmacologique de l’origan (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37530A1 (fr) Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans
BR102019017344A8 (pt) Composições tópicas compreendendo pichia anomala e n-acetil glicosamina
MA37529B1 (fr) Composition pharmacologique de la menthe pouliot (huile essentielle) a effet antibacterien sur l’aggregatibacter actinomycetemcomitans.
MA37531B1 (fr) Composition pharmacologique du bigaradier (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans